Abstract
Patients on oral anticoagulation who present with a ST-segment myocardial infarction and require fibrinolytics therapy represent a high patient population. With limited evidence to guide management, providers must assess risk versus benefit and attempt to mitigate bleeding events.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
O’Gara PT, Kushner FG, Ascheim DD, et al. 2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction. J Am Coll Cardiol. 2013;61(4):e78–e140.
Lip GYH, Windecker S, Huber K, et al. Management of antithrombotic therapy in atrial fibrillation patients presenting with acute coronary syndrome and/or undergoing percutaneous coronary or valve interventions: a joint consensus document of the European Society of Cardiology Working Group on Thrombosis, European Heart Rhythm Association (EHRA), European Association of Percutaneous Cardiovascular Intervention (EAPCI), and the European Association of Acute Cardiac Care (ACCA) endorsed by the Heart Rhythm Society (HRS) and Asia-Pacific Heart Rhythm Society (APHRS). Eur Heart J. 2014;35(45):3155–79.
Sarrinen S, Puolakka J, Boyd J, et al. Warfarin and fibrinolysis-a challenging combination: an observational cohort study. Scand J Trauma Resusc Emerg Med. 2011;19:21.
Bovill E, Terrin M, Stump D, et al. Hemorrhagic events during therapy with recombinant tissue-type plasminogen activator, heparin, and aspirin for acute myocardial infarction: results of the thrombolysis in myocardial infraction (TIMI) phase II trial. Ann Intern Med. 1991;115(4):256–65.
Stanley AG, Fletcher S, Tan A, Barnett DB. Is warfarin a contraindication to thrombolysis in acute ST elevation myocardial infarction? Heart. 2006;92(8):1145–6.
Brass L, Lichtman J, Wang Y, et al. Intracranial haemorrhage associated with thrombolytic therapy for elderly patients with acute myocardial infarction: results from the cooperative cardiovascular project. Stroke. 2000;31:1802–11.
Demaerschalk BM, Kleindorfer DO, Adeoye OM, et al. Scientific rationale for the inclusion and exclusion criteria for intravenous alteplase in acute ischemic stroke: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2016;47:581–641.
Larson DM, Duval S, Sharkey SW, et al. Safety and efficacy of a pharmaco-invasive reperfusion strategy in rural ST-elevation myocardial infarction patients with expected delays due to long-distance transfers. Eur Heart J. 2012;33(10):1232–40.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer International Publishing AG
About this chapter
Cite this chapter
Beavers, C.J. (2017). ST-Segment Elevation Myocardial Infarction (Lytic Candidate) on Oral Anticoagulant. In: Kiser, K. (eds) Oral Anticoagulation Therapy. Springer, Cham. https://doi.org/10.1007/978-3-319-54643-8_26
Download citation
DOI: https://doi.org/10.1007/978-3-319-54643-8_26
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-54641-4
Online ISBN: 978-3-319-54643-8
eBook Packages: MedicineMedicine (R0)